Cardiovascular CDMOs

Jeil Pharmaceutical Co., Ltd.

South Korea

Jeil Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company headquartered in Seoul that offers APIs, finished dosage products, and CMO services. The company has a production capacity of 1.5 billion oral dosage units per year and manufactures tablets, transdermal patches, and other dosage forms. Jeil supplies 62 products including APIs, excipients, and intermediates and is FDA-registered.

Jerome Stevens Pharmaceuticals, Inc.

United States

Jerome Stevens Pharmaceuticals, Inc. (JSP) is a family-owned pharmaceutical manufacturer based in Bohemia, New York, established in 1979. The company specializes in manufacturing prescription tablet and capsule formulations under cGMP standards. JSP is notable for manufacturing UNITHROID, the first FDA-approved Levothyroxine Sodium product, and also produces Digoxin tablets. The company provides CMO services to partners including Amneal Pharmaceuticals.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

China

Jiangsu Nhwa Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company specializing in CNS (Central Nervous System) drugs, listed on Shenzhen Stock Exchange (002262.SZ) since 2008. Founded in 1978, the company is designated as a national production unit for narcotic and psychotropic drugs. Nhwa operates over 10 automated production lines for tablets, capsules, liquid injectables, and powder injectables, covering over 800 acres. The company serves as a major global CNS drug production and R&D base.

Laurus Synthesis

India

Laurus Synthesis is the CDMO subsidiary of Laurus Labs, a prominent Indian pharmaceutical and biotechnology company. It is a Contract Development and Manufacturing Organization with a solid track record in supporting drug development and commercial API supply. Serves as the US-affiliate of Laurus Labs, with key markets in the US, European Union, and Japan. Offers high-potent drug manufacturing capabilities and comprehensive CDMO services from drug substance development through commercial manufacturing.

Life Pharma FZE

United Arab Emirates

Life Pharma FZE (LIFEPharma) is a UAE-based pharmaceutical manufacturer and the only USFDA-approved pharmaceutical company in the United Arab Emirates. Part of VPS Healthcare, the company manufactures a wide range of generic finished dosage forms including tablets, capsules, and liquid oral preparations at its facility in Jebel Ali, Dubai. LIFEPharma is building a new oncology manufacturing facility in Abu Dhabi.

MERRYMED FARM LLC

Uzbekistan

MERRYMED FARM LLC is an Uzbekistan-based pharmaceutical manufacturer. Based on CPHI listings, the company produces finished dosage forms including heparin solutions for injection, and products in cardiovascular, respiratory, gastrointestinal, and other therapeutic categories. The company appears to be a commercial pharmaceutical manufacturer rather than a full-service CDMO with development capabilities.

MSN Laboratories

India

MSN Laboratories is a Hyderabad-based major pharmaceutical CDMO with $1.2 billion in revenue. The company operates 15 API facilities and 6 finished dosage form (FDF) facilities across India and the USA (Novadoz Pharmaceuticals). MSN offers CRAMS (Contract Research and Manufacturing Services) with 200+ first-to-market generics and 400+ formulations. Specialized capabilities include cytotoxics, high-potency APIs, peptides, prostaglandins, and biosimilars. FDA-registered with 14 FEI numbers, 31 FDA inspections (16 NAI, 15 VAI — strong track record), and 119 FDA-approved products. Has established an advanced E&L (Extractables and Leachables) Laboratory.

Nobel Ilac Sanayii Ve Ticaret A.S.

Kazakhstan

Nobel Ilac is a Turkish pharmaceutical company founded in 1964, operating in 20+ countries with representative offices and exporting drug substances and drug products to over 50 countries. The company manufactures both APIs and finished dosage forms, with biotechnology as a declared strategic priority. It is listed as a CMO/CDMO on PharmaSource with contract small molecule API manufacturing capabilities.

Normon

Spain

Laboratorios Normon is a Spanish pharmaceutical company manufacturing generic medicines. Founded as a family company, it has invested over 100 million euros in expansion and operates FDA-registered manufacturing facilities. The company is listed as a CMO/CDMO on PharmaSource and appears in cytotoxic drugs and HPAPI manufacturing market reports, indicating high-potency capabilities.

Novell Pharmaceutical Laboratories

Indonesia

Novell Pharmaceutical Laboratories is one of the largest pharmaceutical companies in Indonesia, manufacturing both oral solid dosage forms (tablets, capsules, powders) and sterile injectable products (liquid and powder). The factory was originally built and operated by a multinational company, and later expanded to Australian TGA standards. The facility features Class A/B/C/D cleanrooms, Bausch & Stroebel filling equipment, Getinge autoclaves, and Lytzen depyrogenation ovens. Novell has 2 FDA-registered FEI numbers, 3 FDA-approved products, and 10 FDA inspections.

Novugen Pharma

Malaysia

Novugen Pharma is a Malaysian pharmaceutical company and CDMO subsidiary of UAE-based SciTech International, providing vertically integrated API and finished dosage form development and manufacturing. The company has USFDA-approved facilities including a dedicated oncology manufacturing plant. Novugen achieved zero Form 483 citations from USFDA and holds Halal pharmaceutical certification.

Pell Tech Healthcare Pvt. Ltd.

India

Pelltech Healthcare is a privately owned WHO-GMP approved Indian pharmaceutical company specializing in the manufacture of conventional and modified-release pellets and finished formulations in capsules and tablets. The company has a dedicated state-of-the-art manufacturing facility focused on pellet-based oral solid dosage forms, taking APIs through formulation development to commercial production.

Pen Tsao Chemical Industry Ltd

China

Pen Tsao Chemical Industry Ltd is a back-integrated manufacturer of APIs, advanced pharma intermediates, and oral solid dosage formulations based in Shanghai, China with over 25 years of experience. The company produces 30+ APIs and formulations from two facilities: a multipurpose plant in Baoshan (56 m3 reactor volume, 218 m3 at Jinshan) and a new site in Pinghu with 270 tons API capacity and 70 tons OSD capacity. Pen Tsao was the first WHO pre-qualified supplier of MDR-tuberculosis drugs.

Pfizer CentreOne

Belgium

Pfizer CentreOne is a global CDMO embedded within Pfizer, specializing in commercial manufacturing of oral solid doses, sterile injectables, biologics including monoclonal antibodies, and antibody-drug conjugates. It leverages Pfizer's global manufacturing network across six continents with cGMP-compliant sites and over 170 years of pharmaceutical manufacturing expertise, backed by $1B+ annual manufacturing investments.

Pharco Corporation

Egypt

Pharco Corporation is the largest pharmaceutical manufacturer in Egypt and the MENA region, comprising 11 companies focused on development, manufacturing, marketing, and distribution of generics and branded generics. The company produces 2.5 million packs daily, exports to 50+ countries, and operates an API manufacturing subsidiary (PBIC) with custom synthesis contracts. Pharco is WHO-prequalified for HCV medicines.

Pharmascience

Canada

Pharmascience is Canada's largest privately-owned pharmaceutical company, a leading manufacturer of generic, branded, and over-the-counter pharmaceuticals. The company has recently expanded its CDMO services with a new commercial business unit, investing over $120 million to expand its sterile injectable manufacturing facility in Candiac, Quebec, aiming to more than triple capacity. Pharmascience's ambition is to become a world leader in the sterile injectable CDMO segment. The company distributes products in over 50 countries and invests approximately $65 million per year in R&D in Canada. The Pendopharm division offers specialty medicines in gastroenterology, orthopedics, and neurology.

Pharma Tech Industries

United States

Pharma Tech Industries (PTI) is a pharmaceutical CDMO specializing exclusively in non-sterile dry powder blending and high-speed packaging. Founded in 1972, the company operates multiple FDA-registered, NSF-compliant, climate-controlled facilities in Georgia and Missouri under strict cGMP standards. PTI provides development to high-volume commercial-scale production for pharmaceutical, OTC drug & personal care, and nutritional health & medical foods. Delivery formats include sachets, stick packs, bottles, pouches, effervescents, tablets, capsules, drug-devices, and medical swabs. The company has onsite GMP analytical/microbiology labs and uses quality systems including Empower, eQMS, EDMS, and ERP Serialization. PTI earned the highest possible score in the 2024 CDP SME environmental evaluation.

Phlow Corporation

United States

Phlow Corporation is a U.S.-based public-benefit pharmaceutical manufacturer specializing in onshore continuous-flow production of medicines and APIs. The company was awarded a landmark $354 million HHS/ASPR/BARDA contract to manufacture essential medicines in shortage, strengthening America's pharmaceutical supply chain. Phlow has raised $37 million in Series C funding to expand U.S.-based CDMO operations. The company partners with Fresenius Kabi for the first-ever end-to-end U.S. manufacturing of Epinephrine Injection USP, with Antheia for advanced manufacturing technologies, and with USP for pharmaceutical continuous manufacturing. Phlow is driving sustainable cost competitiveness through advanced manufacturing technology including continuous flow chemistry and AI-enhanced analytics.

Pinnacle Life Science

India

Pinnacle Life Science is a subsidiary of the Aarti Group, founded in 2015, offering pharmaceutical manufacturing and CDMO services. Operates a state-of-the-art US FDA-approved manufacturing plant in Baddi, India. Produces 3 billion tablet units, 300 million capsule units, and 100 million oncology OSD units annually. Supplies products to 150+ partners in 90+ countries. Therapeutic focus on oncology, cardiovascular, anti-infective, and diabetic segments with 80+ finished products.

Prime Pharmaceuticals Pvt Ltd.

India

Prime Pharmaceuticals Pvt Ltd. (also known as PRIME PHARMACEUTICALS PVT. LTD) is an Indian R&D-driven CMO and CDMO with significant manufacturing capabilities. IMPORTANT NOTE: The website at primepharmaceuticals.in appears to be a different entity -- an ayurvedic/herbal product brand based in Hissar, India. The actual PRIME PHARMACEUTICALS PVT. LTD. on PharmaSource is a contract manufacturer with FDA-registered facilities (3 FEI numbers), 7 FDA inspections (1 NAI, 6 VAI), 4 Class I recalls, clinical trials in cardiovascular/oncology/ophthalmology, and 3 FDA-approved products (cream, spray, tablet via oral and topical routes). They are listed on CPHI for biosimilars, injectables, and contract manufacturing, and appear at CPHI Frankfurt.

Rivopharm SA

Switzerland

Rivopharm SA is a Swiss-based pharmaceutical company focused on the development, manufacture, and marketing of generic pharmaceutical products at a global level. Founded in 1961 and headquartered in Manno (Lugano), the company offers a portfolio of over 100 molecules with more than 2,000 SKUs across a wide range of therapeutic areas. Rivopharm operates internationally through subsidiaries in the UK, Germany, and the Baltics, and has 87 FDF dossiers and 4 FDA registrations.

Senores Group

India

Senores Group (Senores Pharmaceuticals Limited) is an India-based CDMO specializing in complex generic oral solid dosage forms and API manufacturing. The company operates 5 manufacturing facilities including 2 USFDA-approved formulation plants (Atlanta, USA and Gujarat, India) and 2 API/intermediates plants. Senores serves 300+ customers in 49 countries, with particular strength in controlled substances (C2-C5), extended-release, and orally disintegrating tablet formulations.

Serumwerk Bernburg AG

Germany

Serumwerk Bernburg AG is a medium-sized German pharmaceutical company with over 60 years of tradition in the development and production of medicines, medical devices, and APIs. The company offers APIs and contract manufacturing (Lohnproduktion) services, manufactures sterile infusion and rinsing solutions for hospitals and dialysis centers, ophthalmic products, veterinary medicines, wound care products, and specialty biopolymer-based formulations. Serumwerk has FDA-registered API manufacturing and exports to partners in 60+ countries.

SMS Pharmaceuticals Ltd

India

SMS Pharmaceuticals Ltd. is a listed Indian pharmaceutical company and global player in API manufacturing, established in 1990. The company operates four multi-product manufacturing facilities and two research centers, employing over 1,000 people and exporting to 75+ countries. SMS has export house status and is expanding CDMO services with a planned Rs 250 crore expansion.

Sofgen Pharmaceuticals

United States

Sofgen Pharmaceuticals, part of Procaps Group, is an integrated softgel CDMO that offers end-to-end solutions in softgel technologies from development through delivery. The company serves pharmaceutical, OTC, and nutraceutical customers, with operations across 13 countries in the Americas and customers in 50+ countries.

TAPI (Teva API)

Netherlands

TAPI (Teva Active Pharmaceutical Ingredients) is the API division of Teva Pharmaceutical Industries, positioned as the world's leading international supplier of APIs with 350+ products in their portfolio. They offer integrated API and CDMO services, leveraging 85+ years of API development and manufacturing expertise. TAPI provides customized solutions including complex API development, peptide manufacturing (including GLP-1 capability), and end-to-end manufacturing. They have a partnership with Antheia for biosynthetic pharmaceutical ingredients and with Sagimet Biosciences for resmetirom API. TAPI operates globally with multiple manufacturing sites.

Theon Pharmaceuticals Ltd.

India

Indian pharmaceutical contract manufacturer (third-party manufacturer) based in Baddi, Himachal Pradesh. WHO-GMP and ISO 9001:2008 certified. Specializes in manufacturing tablets, capsules, dry syrups, and injectables. Ranked among top 10 leading injectable companies. Launched new state-of-the-art injectable and ophthalmic formulations facility in October 2024 for regulated markets. Has multiple production sections: General, Beta Lactam, Cephalosporins, Dry Powder Injectable. Exports to Africa, South East Asia, CIS, Latin America, and Asia Pacific. Has 12 FDA-approved products including injectables and oral tablets.

Thermo Fisher Scientific Inc.

China

One of the world's largest pharmaceutical CDMOs through its Patheon pharma services division. Provides end-to-end pharmaceutical development and manufacturing services for both small molecules and biologics, from API manufacturing through drug product, sterile fill/finish, packaging, and commercial supply. Operates 31+ FDA-registered facilities globally. 158 FDA inspections on record (52 NAI, 104 VAI, 2 OAI). Also provides cell therapy manufacturing solutions (CTS Rotea cell processing system), laboratory informatics, bioprocessing equipment, and reagents. 4 FDA-approved drug products. Revenue >$40B (full company).

Tiefenbacher Group

Cyprus

Purpose-driven, family-owned healthcare company pioneering healthcare since 1963, headquartered in Cyprus. Delivers best-in-class solutions across the entire pharmaceutical value chain from API distribution through development, manufacturing, and registration of affordable medicines. 900+ employees, 400+ customers, 180+ finished dosage form products, serving patients in 80+ countries. Production capacity up to 3 billion units per year. Manufacturing sites in Cyprus (large-scale oral solid dose, SPC waiver site) and Hyderabad, India (specialized high-potent manufacturing block for oncology, FDA-inspected). Includes Tiefenbacher Laboratories (TBD Pharmatech) as API CDMO division. Offers ICH stability studies, technology transfer, analytical laboratory services, and EU batch testing/release.

Tulip Lab Pvt Ltd

India

Tulip Lab Pvt Ltd is an Indian pharmaceutical manufacturing company headquartered in Mumbai. ISO 22000 certified and PIC/S certified, they manufacture allopathic and herbal products including tablets, capsules, liquids, and topicals. Their product range covers essential care, lifestyle diseases, cardiology, women's well-being, and metabolic disorders. They offer formulation development, private label, and contract manufacturing services with GMP-compliant facilities.

Ultratech India Limited

India

Ultratech India Limited is an integrated Indian pharmaceutical company established in 1992, manufacturing pharmaceutical finished dosage forms, Active Pharmaceutical Ingredients, and drug intermediates. They specialize in pulmonary drug delivery systems (DPI and pMDI inhalation products) and offer Custom Research and Manufacturing Services (CRAMS) including custom synthesis, process development, private labeling, and contract manufacturing. Extensive API portfolio covers cardiovascular, antifungal, antihistamine, anti-asthmatics, antiviral, erectile dysfunction, and other therapeutic segments. WHO GMP, ISO 9001, ISO 14001 certified.

UNI-PHARMA S.A.

Greece

UNI-PHARMA S.A. is a major Greek pharmaceutical company (part of the Tsetis Group) with over 60 years of operations. It researches, develops, produces, and distributes pharmaceutical products, food supplements, and medical devices. It holds the first place in sales (units) among purely Greek companies in the Greek pharmaceutical market. The company offers contract manufacturing services (listed as CMO/CDMO on PharmaSource) while also marketing its own extensive portfolio of generic medicines across multiple therapeutic categories. Their product range includes a very wide array of small-molecule generics.

Unison Pharmaceuticals Private Limited

India

Unison Pharmaceuticals Private Limited is an Indian pharmaceutical company established in 1981, recognized as a Contract Manufacturing Organisation (CMO) providing quality and affordable medicines. They handle testing, production, and full packaging. The company website has minimal content but search results confirm they are a CMO supplying pharmaceutical formulations including tablets.

Xi'an Wanlong Pharmaceutical

China

Xi'an Wanlong Pharmaceutical Co., Ltd. is a comprehensive modern pharmaceutical enterprise founded in 1995, primarily producing formulations, APIs, and intermediates with GMP and DMF compliance. The Yangling facility spans 200,000 sq.m. with 18 production lines for injections, tablets, capsules, powder, and raw materials.

XL LABORATORIES PVT LTD

India

XL Laboratories Pvt Ltd is an EU GMP, PIC/s, TGA, and WHO GMP approved pharmaceutical formulations and nutraceuticals research and manufacturing company established in 2001. It holds Star Export House status from the Indian Ministry of Commerce for outstanding international market performance, with presence in 40+ countries.

ACON Pharmaceuticals

United States

ACON Pharmaceuticals Inc is a specialty contract research organization (CRO) based in Cranbury, New Jersey, focused on drug product development. They specialize in drug delivery systems including siRNA, mRNA, liposomes, nanocrystals, and complex generics development via the 505(b)(2) pathway. They are primarily a development-focused CRO, not a manufacturing organization.

Ami Lifesciences Pvt Ltd

India

Ami Lifesciences Pvt. Ltd. is one of India's fastest-growing API manufacturing companies, established in 2006 in Vadodara, Gujarat. The company manufactures 88+ APIs across multiple therapeutic areas with 69 DMFs filed globally, operating three manufacturing plants with 1,500 metric tons of production capacity and offering CDMO/custom synthesis services.

Atlas Life Sciences Private Limited

India

Atlas Life Sciences Private Limited, a division of Atlas Dyechem (India), is an Indian API manufacturer established in 2009. They specialize in small molecule APIs including Pregabalin (anticonvulsant), Phenylephrine HCl (decongestant), Levosulpiride and Amisulpride (antipsychotics), Gliclazide (antidiabetic), and upcoming APIs including Azilsartan, Ticagrelor, and Chlorthalidone. Their WHO GMP-accredited manufacturing unit is in India.

Changzhou Comwin Fine Chemicals Co., Ltd

China

Changzhou ComWin Fine Chemicals Co., Ltd., a subsidiary of ComWin International established in 2003, specializes in producing and distributing APIs, animal healthcare products, and nutritional ingredients. The company operates a 70,000 sqm manufacturing site in Taizhou, China, and provides international logistics services including cold-chain and hazardous shipment to clients such as Sanofi and Vetoquinol.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB)

Taiwan

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB), founded in 1964 and operating as Cenra API Solutions, is one of the largest API manufacturers in Taiwan. The company provides cGMP toll manufacturing and contract research services with FDA/EU-approved facilities, producing APIs across antifungal, immunosuppressant, oncology, cardiovascular, and peptide drug categories.

Codexis, Inc.

United States

Codexis, Inc. is a US-based enzyme engineering and biocatalysis company that provides contract manufacturing of RNA therapeutics through its ECO Synthesis Manufacturing Platform, as well as pharmaceutical biocatalysis services for small molecule API manufacturing. The company uses proprietary enzyme-enabled platforms to deliver enzymatic RNA synthesis (siRNA, mRNA) as an alternative to traditional chemical synthesis, offering higher purity, yield, and sustainability.

Deccan Nutraceuticals Pvt. Ltd. (DNPL)

India

Deccan Nutraceuticals Pvt. Ltd. (DNPL) is an Indian API manufacturer and group company of Alkaloids Corporation, primarily producing active pharmaceutical ingredients, intermediates, and botanical/phytopharmaceutical extracts. Operating from a 22,000 sqm FDA-authorized, USFDA and EDQM inspected facility, DNPL has a portfolio of over 100 products including plant-based, semi-synthetic, and synthetic APIs. The company exports to major markets including USA, EU, Australia, and Canada.

Emil Pharmaceutical Industries Pvt Ltd

India

Emil Pharmaceutical Industries Pvt. Ltd. is an Indian CDMO founded in 1989, headquartered in Mumbai with three manufacturing units in MIDC Tarapur, Maharashtra. The company manufactures pharmaceuticals, nutraceuticals, and OTC formulations including tablets, capsules, powders, liquids, creams, and ointments. Emil has partnered as a CDMO with global companies including Abbott, Mylan, Pfizer, GSK, USV, and MSD, and exports to over 25 countries with certifications from WHO, ISO 9001, NAFDAC Nigeria, and FDA Ghana.

GL Biochem (Shanghai) Ltd.

China

GL Biochem (Shanghai) Ltd. is a peptide and API contract development and manufacturing organization founded in 2001. The company specializes in custom peptide synthesis, peptide APIs, and small molecule API manufacturing, with FDA- and EU GMP-registered facilities in Shanghai. It serves global pharmaceutical clients with products ranging from research-grade peptides to cGMP commercial-scale production.

Glenmark (incl. API arm Glenmark Life Sciences)

Argentina

Glenmark Pharmaceuticals is a global innovation-driven pharmaceutical company focused on branded and generic formulations, with an API manufacturing arm called Glenmark Life Sciences. The company manufactures APIs and finished dosage forms primarily for its own portfolio, spanning dermatology, respiratory, oncology, and cardiovascular therapeutic areas. Glenmark Life Sciences produces over 120 APIs across multiple manufacturing sites in India.

Global Pharma HealthCare (India)

India

Global Pharma HealthCare is an Indian pharmaceutical CDMO offering contract development and manufacturing services for sterile and non-sterile dosage forms. The company provides end-to-end services from formulation development through commercial manufacturing, including oral solids, liquids, sterile injectables, and lyophilized products. It serves regulated markets including the US, EU, and other global markets.

Globela Pharma Pvt Ltd

India

Globela Pharma Pvt Ltd is an Indian pharmaceutical company founded in 2006, offering CDMO, CRAMS, and API manufacturing services. The company has specialized EU GMP-certified facilities for oncology (cytotoxic) and cephalosporin manufacturing, with a DSIR-approved R&D center and exports to over 50 countries. It provides end-to-end services from API and intermediate manufacturing through finished dosage form production.

Granules (Granules India)

India

Granules India Limited is a vertically integrated pharmaceutical company and CDMO specializing in high-volume oral solid dosage manufacturing from APIs through finished dosage forms. The company is one of the largest manufacturers of core molecules such as paracetamol, metformin, guaifenesin, and ibuprofen, operating multiple FDA- and EU GMP-approved manufacturing facilities across India and the US. It provides contract manufacturing services for global pharmaceutical companies.